CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleMarket cap is $1.38B, above the global median of $1.18B
- FinancialsAltman Z-Score 13.48: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.71%
Annual Rate
CNY 0.14Paid annual
Payout Ratio
36.7%Sustainable
Last Ex-Dividend
Jun 25, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.22BCNY1.38B · vs all stocks (USD)
Trailing P/E
41.71xRevenue (TTM)
1.61BCNY239.68M · vs all stocks (USD)
Profit Margin
13.95%Beta
0.3950xvs all stocks
52-Week Change
-23.10%vs all stocks
Market Capitalization
9.22BCNY1.38B · vs all stocks (USD)
Enterprise Value
9.20BCNY1.37B · vs all stocks (USD)
Trailing P/E
41.71xForward P/E
19.65xPrice to Sales (TTM)
5.74xPrice to Book (MRQ)
3.33xEnterprise to Revenue
5.73xEnterprise to EBITDA
42.58xGross Margin
39.59%Profit Margin
13.95%Operating Margin
9.76%Return on Assets (TTM)
3.46%Return on Equity (TTM)
7.41%Revenue (TTM)
1.61BCNY239.68M · vs all stocks (USD)
Revenue per Share (TTM)
3.56CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-15.50%Gross Profit (TTM)
602.35MCNY89.88M · vs all stocks (USD)
EBITDA (TTM)
180.41MCNY26.92M · vs all stocks (USD)
Net Income (TTM)
224.00MCNY33.42M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-29.90%Operating Cash Flow (TTM)
157.93MCNY23.57M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-104.76MCNY-15.63M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1450CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.71%vs all stocks
Payout Ratio
36.73%Minority Interest (Equity)
17.39MCNYFY2025 · Dec 31, 2025Revenue
1.83BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.19BCNYFY2025 · Dec 31, 2025Gross Profit
643.35MCNYFY2025 · Dec 31, 2025Operating Income
234.52MCNY35.00M · vs all stocks (USD)
Pre-tax Income
287.60MCNYFY2025 · Dec 31, 2025Income Tax Expense
2.99MCNYFY2025 · Dec 31, 2025Net Income
284.61MCNYFY2025 · Dec 31, 2025EBIT
288.69MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
312.19MCNYFY2025 · Dec 31, 2025Research & Development
317.48MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
41.37MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.10MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
15.41MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.09MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.6500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.6400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
447.16MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
447.16MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
284.61MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
6.04MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
441.45MCNYFY2025 · Dec 31, 2025Free Cash Flow
320.52MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
509.19MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
284.61MCNYFY2025 · Dec 31, 2025Other Non-cash Items
2.15MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
24.72MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
129.97MCNYFY2025 · Dec 31, 2025Capital Expenditures
-120.93MCNYFY2025 · Dec 31, 2025Net Acquisitions
5.98MCNYFY2025 · Dec 31, 2025Purchase of Investments
-300.00MCNYFY2025 · Dec 31, 2025Sale of Investments
263.65MCNYFY2025 · Dec 31, 2025Other Investing Activity
-214.90MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-366.20MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
34.80MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-109.44MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-72.33MCNYFY2025 · Dec 31, 2025Other Financing Charges
25.09MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-121.88MCNYFY2025 · Dec 31, 2025Shares Outstanding
451.21MSharesUpdated Sep 21, 2026Float Shares
274.28MSharesUpdated Sep 21, 2026% Held by Insiders
44.69%vs all stocks
% Held by Institutions
1.29%vs all stocks
Total Cash (MRQ)
1.19BCNY177.67M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.41CNYUpdated Sep 21, 2026Total Debt (MRQ)
268.69MCNY40.09M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0880xCurrent Ratio (MRQ)
3.63xBook Value per Share (MRQ)
6.13CNYUpdated Sep 21, 2026Total Assets
3.52BCNY525.08M · vs all stocks (USD)
Total Current Assets
2.76BCNYFY2025 · Dec 31, 2025Total Liabilities
486.70MCNYFY2025 · Dec 31, 2025Total Non-current Assets
756.92MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
25.30MCNYFY2025 · Dec 31, 2025Total Current Liabilities
461.41MCNYFY2025 · Dec 31, 2025Cash
1.23BCNYFY2025 · Dec 31, 2025Cash Equivalents
7.15MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.24BCNYFY2025 · Dec 31, 2025Other Short-term Investments
446.33MCNYFY2025 · Dec 31, 2025Accounts Receivable
347.70MCNYFY2025 · Dec 31, 2025Inventory
71.12MCNYFY2025 · Dec 31, 2025Accounts Payable
172.99MCNYFY2025 · Dec 31, 2025Short-term Debt
30.69MCNYFY2025 · Dec 31, 2025Other Current Liabilities
149.15KCNYFY2025 · Dec 31, 2025Long-term Debt
13.05MCNYFY2025 · Dec 31, 2025Common Stock (Book)
451.21MCNYFY2025 · Dec 31, 2025Retained Earnings
1.34BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.03BCNY452.46M · vs all stocks (USD)
Treasury Stock
16.74MCNYFY2025 · Dec 31, 202552-Week Low
17.33CNYUpdated Sep 21, 202652-Week High
36.50CNYUpdated Sep 21, 202652-Week Change
-23.10%vs all stocks
Beta
0.3950xvs all stocks
50-Day MA
19.55CNYUpdated Sep 21, 2026200-Day MA
24.28CNYUpdated Sep 21, 2026Avg 10-Day Volume
7.87MSharesUpdated Sep 21, 2026Avg 30-Day Volume
12.68MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.4900CNYUpdated Sep 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 13.48: safe zoneNotable
Altman Z-Score: 13.48
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $1.38B, above the global median of $1.18BNotable
Market cap (USD): 1,376,218,873.779Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Certara, Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InRuleFlow
Indegene Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowInterface
Shenzhen Kingdom Sci-Tech Co. Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Cloudwalk Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InRuleProduction
Trs Information Technology Co.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
ZoomInfo Technologies Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowInterface
Amplitude, Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceFlow
NSD Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowProduction
Hangzhou Raycloud Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowProduction
Rategain Travel Technologies Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Sk Biopharmaceuticals Co., Ltd.
2 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMinimal Tax and Interest Drag
PharmaEngine, Inc.
2 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesClose Below 40W SMA With Profitability
Zhangjiagang Freetrade Science & Technology Co. Ltd.
2 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesClose Below 40W SMA With Profitability